Management of recurrence and follow-up strategies for patients with nonseminoma testis cancer.
This review serves as an outline of the clinical features and management options for the majority of recurrence situations in NSGCTs. The combination of reliable serum tumor markers, improved imaging techniques, effective cisplatin chemotherapy regimens, and application of meticulous surgical techniques has resulted in dramatic improvements in cure rates in NSGCT. These factors have caused the incidence of recurrent NSGCT to decline substantially in the past 20 years. This rarity of recurrence in combination with the low incidence of NSGCT prevents the practicing clinician from accumulating experience in this challenging patient population. Therefore, to ensure improvement in salvage rates, patients are best managed in centers with extensive experience in NSGCT.
Jewett
Michael A S
MA
Division of Urology, University of Toronto, 610 University Avenue, 3-130 Toronto, Ontario, Canada M5G 2M9. m.jewett@utoronto.ca
Grabowski
Arthur
A
McKiernan
James
J
D017024:Chemotherapy, Adjuvant; D005500:Follow-Up Studies; D018237:Germinoma / Q000628:therapy*; D006801:Humans; D008197:Lymph Node Excision; D008297:Male; D009919:Orchiectomy; D012008:Recurrence; D013736:Testicular Neoplasms / Q000628:therapy*